Zions Bancorporation NA
SWB:ZB1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zions Bancorporation NA
SWB:ZB1
|
US |
|
I
|
ImpediMed Ltd
OTC:IPDQF
|
AU |
|
G
|
Genmab A/S
OTC:GNMSF
|
DK |
|
Planisware SA
F:Z421
|
FR |
|
Sega Sammy Holdings Inc
TSE:6460
|
JP |
|
B
|
Befesa SA
DUS:BFSA
|
LU |
|
S
|
Stellus Capital Investment Corp
F:GO0
|
US |
|
B
|
Brenntag SE
XMUN:BNR
|
DE |
|
Stellus Capital Investment Corp
NYSE:SCM
|
US |
|
A
|
Alphatime Acquisition Corp
NASDAQ:ATMC
|
US |
|
VEEM Ltd
OTC:VEEMF
|
AU |
|
E
|
Epsium Enterprise Ltd
NASDAQ:EPSM
|
MO |
|
G
|
Goodbridge Capital Corp
OTC:IDXMF
|
CA |
Wall St Price Targets
ZB1 Price Targets Summary
Zions Bancorporation NA
According to Wall Street analysts, the average 1-year price target for ZB1 is 60.2 EUR with a low forecast of 54.84 EUR and a high forecast of 72.4 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZB1's stock price target?
Price Target
60.2
EUR
According to Wall Street analysts, the average 1-year price target for ZB1 is 60.2 EUR with a low forecast of 54.84 EUR and a high forecast of 72.4 EUR.
What is the Revenue forecast for Zions Bancorporation NA?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 8 years is 3%.
What is the Net Income forecast for Zions Bancorporation NA?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 4%.
